SCHOTT Pharma, the pharma drug containment solutions and delivery systems company, has unveiled a groundbreaking nest design for ready-to-use cartridges to improve operational efficiency and sustainability for pharmaceutical manufacturing. The new design optimizes the arrangement of cartridges, reducing the risk of breakage and contamination during high-speed automated filling, and enhancing productivity by streamlining the fill-and-finish process, resulting in faster handling and increased throughput.

Schreiner MediPharm, a leading developer of functional labels for healthcare, has created a specialized Light-Protect-Label for CRDMO, WuXi XDC, to support the dual needs of light protection and drug blinding, to accelerate the process for a novel ADC in clinical trials.

Thermo Fisher Scientific is expanding its oral solid dose (OSD) development and manufacturing capabilities across North America with a $22 mn investment in its Cincinnati, Ohio, and Bend, Oregon sites. The expansion enhances R&D, manufacturing, and testing capabilities to support early drug development and accelerate clinical timelines, and the upgrades include new facilities for advanced drug delivery and formulation technologies, addressing challenges in solubility and bioavailability.

Ask any executive why they think there are drug shortages, and they will no doubt blame some combination of the long-lasting impact of the global pandemic, inflation, energy costs and global conflicts.

A significant rise in biotech stocks has been partly attributed to escalating fears over avian influenza and the ongoing development of related vaccines.

To respond to a greater proportion of clients’ projects requiring potent drug capabilities, specialist oral dose CDMO Adare is to extend its high potency handling and packaging capabilities in Philadelphia, Vandalia in Ohio, and Milan, Italy.

At the CPHI Pharma Awards, CDMO Catalent scooped first place in the Supply Chain Excellence category. The company’s case management services provide professional end-to-end supply chain management and orchestration for autologous and allogeneic cell and gene therapies, and is designed to address the unique challenges associated with the safe and timely delivery of ATMPs.